The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda
Open accessAbstract
BACKGROUND: Adherence to and completion of tuberculosis (TB) treatment remain problematic in many high-burden countries. 99DOTS is a low-cost digital adherence technology that could increase TB treatment completion. METHODS AND FINDINGS: We conducted a pragmatic stepped-wedge cluster-randomized trial including all adults treated for drug-susceptible pulmonary TB at 18 health facilities across Uganda over 8 months (1 December 2018-31 July 2019). Facilities were randomized to switch from routine (control period) to 99DOTS-based (intervention period) TB treatment supervision in consecutive months. Patients were allocated to the control or intervention period based on which facility they attended and their treatment start date. Health facility staff and patients were not blinded to the intervention. The primary outcome was TB treatment completion. Due to the pragmatic nature of the trial, the primary analysis was done according to intention-to-treat (ITT) and per protocol (PP) principles. This trial is registered with the Pan African Clinical Trials Registry (PACTR201808609844917). Of 1,913 eligible patients at the 18 health facilities (1,022 and 891 during the control and intervention periods, respectively), 38.0% were women, mean (SD) age was 39.4 (14.4) years, 46.8% were HIV-infected, and most (91.4%) had newly diagnosed TB. In total, 463 (52.0%) patients were enrolled on 99DOTS during the intervention period. In the ITT analysis, the odds of treatment success were similar in the intervention and control periods (adjusted odds ratio [aOR] 1.04, 95% CI 0.68-1.58, p = 0.87). The odds of treatment success did not increase in the intervention period for either men (aOR 1.24, 95% CI 0.73-2.10) or women (aOR 0.67, 95% CI 0.35-1.29), or for either patients with HIV infection (aOR 1.51, 95% CI 0.81-2.85) or without HIV infection (aOR 0.78, 95% CI 0.46-1.32). In the PP analysis, the 99DOTS-based intervention increased the odds of treatment success (aOR 2.89, 95% CI 1.57-5.33, p = 0.001). The odds of completing the intensive phase of treatment and the odds of not being lost to follow-up were similarly improved in PP but not ITT analyses. Study limitations include the likelihood of selection bias in the PP analysis, inability to verify medication dosing in either arm, and incomplete implementation of some components of the intervention. CONCLUSIONS: 99DOTS-based treatment supervision did not improve treatment outcomes in the overall study population. However, similar treatment outcomes were achieved during the control and intervention periods, and those patients enrolled on 99DOTS achieved high treatment completion. 99DOTS-based treatment supervision could be a viable alternative to directly observed therapy for a substantial proportion of patients with TB. TRIAL REGISTRATION: Pan-African Clinical Trials Registry (PACTR201808609844917).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Health facilities, strategically chosen as clusters in numerous studies, underscore the emphasis on healthcare delivery and interventions within controlled environments.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Administrative units such as districts and wards allowed for evaluating public health interventions across larger populations (26–28, 30, 33, 34, 36, 38, 42, 47, 51, 52, 62, 69, 71–73, 75–79, 84–86, 91, 92, 94–97, 99, 101, 104, 108, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The everyday use of hospitals and clinics as clusters is rooted in their pivotal role in healthcare delivery, enabling the implementation and evaluation of interventions to enhance patient outcomes (26, 27, 30–34, 36–47, 49, 50, 52–71, 73–75, 77–81, 83–89, 91–96, 98–102, 104, 105, 107, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Simple randomization, often using computer-generated sequences, was a standard method employed to determine the order in which clusters received the intervention (26, 30, 32, 35, 38, 47, 58, 65).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies focused on implementing health technologies and digital solutions to improve healthcare delivery and patient outcomes (26, 27, 32, 54, 62, 79, 85, 90, 91, 94, 98, 101, 104, 105).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
Noyes, J., & Popay, J. (2007) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2006.04092.x · Cited by 272
Liu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001876 · Cited by 234
Guidelines for treatment of drug-susceptible tuberculosis and patient care-2017 update
Gao, J., Wang, X., Fu, L., & Du, J. (2018) · Chinese Journal of Asthma · doi:10.3760/cma.j.issn.1673-436x.2018.03.001 · Cited by 231
Story, A., Aldridge, R. W., Smith, C. M., Garber, E., Hall, J., Ferenando, G., Possas, L., Hemming, S., Wurie, F., Luchenski, S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32993-3 · Cited by 213
Browne, S. H., Umlauf, A., Tucker, A. J., Low, J., Moser, K., Garcia, J. G., Peloquin, C. A., Blaschke, T. F., Vaida, F., & Benson, C. A. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002891 · Cited by 98
Self-citationDigital Health Support in Treatment for Tuberculosis
Yoeli, E., Rathauser, J., Bhanot, S. P., Kimenye, M. K., Mailu, E., Masini, E., Owiti, P., & Rand, D. G. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1806550 · Cited by 62
McLaren, Z. M., Milliken, A., Meyer, A. J., & Sharp, A. R. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1862-y · Cited by 61
Thekkur, P., Kumar, A. M. V., Chinnakali, P., Selvaraju, S., Bairy, R., Singh, A. R., Nirgude, A. S., Selvaraj, K., Venugopal, V., & Shastri, S. G. (2019) · Global Health Action · doi:10.1080/16549716.2019.1568826 · Cited by 61
Research works printed but not linked: 3
- World Health Organization, 2017, Global tuberculosis report 2017
- Everwell Health Solutions, 2021, 99DOTS: low-cost monitoring and improving medication adherence
- StataCorp, 2017, Stata statistical software. Release 15
Cited by
Liu, X., Thompson, J., Dong, H., Sweeney, S., Li, X., Yuan, Y., Wang, X., He, W., Thomas, B., Xu, C., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00068-2 · Cited by 69
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · BMC Medicine · doi:10.1186/s12916-022-02521-y · Cited by 53
Wei, X., Hicks, J. P., Zhang, Z., Haldane, V. E., Pasang, P., Li, L., Yin, T., Zhang, B., Li, Y., Pan, Q., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02270-5 · Cited by 53
Jerene, D., van Kalmthout, K., Levy, J., Alacapa, J., Deyanova, N., Dube, T., Mganga, A., Tasca, B. G., Bogdanov, A., Efo, E., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02847-2 · Cited by 42
Mohamed, M. S., Zary, M., Kafie, C., Chilala, C. I., Bahukudumbi, S., Foster, N., Gore, G. C., Fielding, K., Subbaraman, R., & Schwartzman, K. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11503-3 · Cited by 46
Tadesse, A. W., Mohammed, Z., Foster, N., Quaife, M., McQuaid, C. F., Levy, J., van Kalmthout, K., van Rest, J., Jerene, D., Abdurhman, T., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06833-x · Cited by 37
Chen, A. Z., Kumar, R., Baria, R. K., Shridhar, P. K., Subbaraman, R., & Thies, W. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08418-2 · Cited by 32
Leddy, A. M., Jaganath, D., Triasih, R., Wobudeya, E., de Oliveira, M. C. B., Sheremeta, Y., Becerra, M. C., & Chiang, S. S. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac058 · Cited by 48
Marley, G., Zou, X., Nie, J., Cheng, W., Xie, Y., Liao, H., Wang, Y., Tao, Y., Tucker, J. D., Sylvia, S., et al. (2023) · PLOS Medicine · doi:10.1371/journal.pmed.1004091 · Cited by 28
Gichuhi, H. W., Magumba, M. A., Kumar, M., & Mayega, R. W. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001466 · Cited by 37
Jerene, D., Levy, J., van Kalmthout, K., Rest, J. V., McQuaid, C. F., Quaife, M., Charalambous, S., Gamazina, K., Garfin, A. M. C., Mleoh, L., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068685 · Cited by 27
Thompson, R. R., Kityamuwesi, A., Kuan, A., Oyuku, D., Tucker, A., Ferguson, O., Kunihira Tinka, L., Crowder, R., Turyahabwe, S., Cattamanchi, A., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.12.002 · Cited by 22
“Staff $47 (2-84) $651 $3711 (2304-5603) $3711 (2304-5603)”
Self-citationPatient perceptions of video directly observed therapy for tuberculosis: a systematic review
Chen, E. C., Owaisi, R. B., Goldschmidt, L., Maimets, I., & Daftary, A. (2023) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2023.100406 · Cited by 22
Boutilier, J. J., Yoeli, E., Rathauser, J., Owiti, P., Subbaraman, R., & Jónasson, J. O. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-010512 · Cited by 25
Leddy, A. M., Ggita, J. M., Berger, C. A., Kityamuwesi, A., Sanyu, A. N., Tinka, L. K., Crowder, R., Turyahabwe, S., Katamba, A., & Cattamanchi, A. (2023) · Journal of Medical Internet Research · doi:10.2196/38828 · Cited by 19
Self-citationmHealth to improve implementation of TB contact investigation: a case study from Uganda
Gupta, A. J., Turimumahoro, P., Ochom, E., Ggita, J. M., Babirye, D., Ayakaka, I., Mark, D., Okello, D. A., Cattamanchi, A., Dowdy, D. W., et al. (2023) · Implementation Science Communications · doi:10.1186/s43058-023-00448-w · Cited by 18
Self-citationChilala, C. I., Foster, N., Bahukudumbi, S., Mohamed, M. S., Zary, M., Kafie, C., Patel, B., Gore, G. C., Schwartzman, K., Subbaraman, R., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016535 · Cited by 25
Kiwanuka, N., Kityamuwesi, A., Crowder, R., Guzman, K., Berger, C. A., Lamunu, M., Namale, C., Kunihira Tinka, L., Nakate, A. S., Ggita, J., et al. (2023) · PLOS Digital Health · doi:10.1371/journal.pdig.0000138 · Cited by 17
“This study was embedded within a stepped-wedge randomized trial that assessed the effectiveness of 99DOTS-based treatment supervision in comparison to routine care [12,13].”
MethodSelf-citationSubbaraman, R., Thomas, B. E., Kumar, J. V., Lubeck-Schricker, M., Khandewale, A. S., Thies, W., Eliasziw, M., Mayer, K. H., & Haberer, J. E. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab532 · Cited by 18
Cheng, Q., Chen, P., Dai, R., Jia, Q., Bai, X., Cao, Q., Li, Q., Wu, Y., & Huang, Y. (2025) · JMIR mhealth and uhealth · doi:10.2196/75424 · Cited by 14
Ghimire, S., Iskandar, D., van der Borg-Boekhout, R., Zenina, M., Bolhuis, M. S., Kerstjens, H. A. M., van Rossum, M., Touw, D. J., Zijp, T. R., van Boven, J. F. M., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01690-2022 · Cited by 14
Wang, X., Qian, F., Zhou, M., & Li, Y. (2023) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2023.0084 · Cited by 11
Acharya, S., Mishra, S. R., von Seidlein, L., Adhikari, B., & Parker, D. M. (2026) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2026.103390 · Cited by 12
Leung, C. L., Alacapa, J., Tasca, B. G., Villanueva, A., Masulit, S., Ignacio, M. L., Uy, K. N., Pell, C. L., van Kalmthout, K., Powers, R., et al. (2024) · JMIR Human Factors · doi:10.2196/54117 · Cited by 14
Tadesse, A. W., Sahile, M., Foster, N., McQuaid, C. F., Weldemichael, G. T., Abdurhman, T., Mohammed, Z., Belachew, M., Shiferaw, A., Assefa, D., et al. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.100895 · Cited by 12
Huda, M. H., Rahman, M. F., Zalaya, Y., Mukminin, M. A., Purnamasari, T., Hendarwan, H., Su’udi, A., Hasugian, A. R., Yuniar, Y., Handayani, R. S., et al. (2024) · PLOS ONE · doi:10.1371/journal.pone.0312001 · Cited by 8
The use of digital technologies in adherence to anti-tuberculosis treatment
Fielding, K., Subbaraman, R., Khan, A. R., Celan, C., Charalambous, S., Franke, M. F., Huddart, S., Katamba, A., Law, S. J., & Stagg, H. R. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10002223 · Cited by 8
Self-citationFoster, N., Tadesse, A. W., McQuaid, C. F., Goscé, L., Abdurhman, T., Assefa, D., Bedru, A., Houben, R. M. G. J., van Kalmthout, K., Letta, T., et al. (2023) · Trials · doi:10.1186/s13063-023-07289-x · Cited by 10
An Inca trail to the Holy Grail: digital medication adherence support for TB care
van Boven, J. F. M., & Alffenaar, J.-W. C. (2021) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0613 · Cited by 9
Qin, N., Chen, J., Chen, L., Hu, W., Yan, F., Xu, C., Zhang, H., Hou, Y., Tang, L., Shen, X., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-018022 · Cited by 11
Pinargote-Chancay, R.-D.-R. (2023) · Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida · doi:10.35381/s.v.v7i14.2567 · Cited by 7
Assessing the Value of Remote Patient Monitoring Solutions in Addressing Challenges in Patient Care
Devine, B. (2022) · Value in Health · doi:10.1016/j.jval.2022.03.020 · Cited by 7
Goscé, L., Tadesse, A. W., Foster, N., van Kalmthout, K., van Rest, J., van der Wal, J., Harker, M. J., Madden, N., Abdurhman, T., Gadissa, D., et al. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2024-016997 · Cited by 8
Community-based interventions to improve tuberculosis treatment outcomes: A meta-analysis
Kedthongma, W., Usaprom, S., & Phakdeekul, W. (2026) · MethodsX · doi:10.1016/j.mex.2026.103893 · Cited by 11
Scale-up of 99DOTS for TB treatment supervision: an interrupted time series analysis
Crowder, R., Nakasendwa, S., Kityamuwesi, A., Musoke, M., Nannozi, J., Waswa, J., Sanyu, A. N., Lamunu, M., Twinamasiko, A., Tinka, L. K., et al. (2025) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.24.0587 · Cited by 5
Self-citationSubbaraman, R., Haberer, J. E., & Fielding, K. (2022) · Value in Health · doi:10.1016/j.jval.2022.09.008 · Cited by 5
Madden, N., Tadesse, A. W., Leung, C. L., Tasca, B. G., Alacapa, J., Deyanova, N., Ndlovu, N. T., Mokone, N., Onjare, B., Mganga, A., et al. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10030068 · Cited by 6
Kajian Naratif: Intervensi untuk Meningkatkan Kepatuhan Pengobatan Tuberculosis
Mahwati, Y. (2022) · Kesmas Indonesia · doi:10.20884/1.ki.2022.14.2.5655 · Cited by 5
Sivashanmugam, M., & Mahendran, R. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1644_2024 · Cited by 6
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
Sweeney, S., Fielding, K., Liu, X., Thompson, J. A., Dong, H., Jiang, S., Zhao, Y., Huan, S., & Vassall, A. (2024) · IJTLD OPEN · doi:10.5588/ijtldopen.23.0451 · Cited by 6
Reflective Study of Information Technology Utilization in Maternal Anemia Prevention Programs
Alamsyah, S. S., Falah, Y. F., Sari, A. A. D. P., Sari, N. A. S. A., & Arifah, I. (2023) · Jurnal Kesehatan · doi:10.23917/jk.v16i3.2089 · Cited by 3
Browne, S. H., Umlauf, A., Moore, D. J., Benson, C. A., & Vaida, F. (2024) · JMIR mhealth and uhealth · doi:10.2196/53596 · Cited by 4
Dewanti, G. P., & Masfuri, M. (2023) · Majalah Keperawatan Unpad/Journal of Nursing Care · doi:10.24198/jnc.v6i1.43412 · Cited by 3
Dovel, K. L., Hubbard, J., Zembe, L., Ford, N. P., Cornell, M., Belshe, W. B., Long, L. C., Davis, S., Munderi, P., Baggaley, R. C., et al. (2023) · medRxiv · doi:10.1101/2023.10.25.23297534 · Cited by 4
Li, W., Wu, S., Su, M., Saad, A., Zhang, W., Fan, X., Li, R., Gao, Y., & Wei, X. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00587-5 · Cited by 2
Use of a digital adherence technology to support TB treatment among adolescents
Schraufnagel, A., Crowder, R., Wambi, P., Nakasendwa, S., Kityamuwesi, A., Jaganath, D., Musoke, M., Nannozi, J., Waswa, J., Sanyu, A. N., et al. (2025) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.24.0663 · Cited by 2
Self-citationAfandi, A. T., Putri, P., & Rondhianto (2026) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2026.04.016 · Cited by 2
Duan, Y., Liu, J., Lin, S., Li, X., Luo, D., & Zhu, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1840258 · Cited by 2
Ssedyabane, F., Randall, T. C., Kajabwangu, R., Namuli, A., Tusubira, D., Kakongi, N., Galiwango, M., Maling, S., Turyakira, E., & Atukunda, E. C. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101338 · Cited by 2
Putting technology to the test in tuberculosis care
Subbaraman, R., & Fielding, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00412-4 · Cited by 3
Appraising perception, accessibility and uptake of DAT among patients with TB
Ogbudebe, C. L., Odume, B. B., Gordon, I., Chukwuogo, O., Nwokoye, N. N., Useni, S., Efo, E., Gidado, M., Aniwada, E., Ihesie, A., et al. (2024) · Public Health Action · doi:10.5588/pha.24.0009 · Cited by 2
Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses
Dowdy, D. W., Thompson, R. R., Kityamuwesi, A., Crowder, R., Cattamanchi, A., Katamba, A., & Sohn, H. (2022) · Value in Health · doi:10.1016/j.jval.2022.09.2479 · Cited by 2
Self-citationFoster, N., Tadesse, A. W., Belachew, M., Sahile, M., McQuaid, C. F., Goscé, L., Bedru, A., Abdurhman, T., Umeta, D. G., Shiferaw, A., et al. (2024) · medRxiv · doi:10.1101/2024.07.28.24310767 · Cited by 3
Guzmán, J. A. C., Melgen, R. E., Mendoza, E. R., Arias, L. F., Espinal, R., Báez, J., & Iribarren, S. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1529687 · Cited by 1
Mukora, R., Pelusa, R., Maraba, N., Orrell, C., Jennings, L., Naidoo, P., Velen, K., Fielding, K., Dowdy, D. W., Sweeney, S., et al. (2026) · BMC Public Health · doi:10.1186/s12889-026-28361-6 · Cited by 1
Self-citationShah, P., Zaidi, I., Adil, M., Gurav, J., Kutikuppala, L. V. S., Tummala, N., Sojitra, V., & Suvvari, T. K. (2025) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_65_25 · Cited by 1
ESTRATÉGIAS PARA ADESÃO AO TRATAMENTO DA TUBERCULOSE PULMONAR: REVISÃO INTEGRATIVA
de Almeida, M. E., Carvalho, A. L., Queiroz, E. H. B., & Alves, M. G. (2026) · Revista Atenas Higeia · doi:10.71409/ah.v8i1.596 · Cited by 1
Climate change and tuberculosis: enhancing impact through an implementation science informed agenda
Christian, C., Mukondwa, R. W., Webb, K. A., & Shete, P. B. (2026) · Environmental Health · doi:10.1186/s12940-026-01273-z · Cited by 1
Digital solutions for tuberculosis surveillance and control in primary health care: a scoping review
Sacramento, D. S., Mendonça, S. A. A., de Farias, A. S., & Sampaio, V. D. S. (2026) · Epidemiologic Reviews · doi:10.1093/epirev/mxag008 · Cited by 1
Patient-centered and technology-enabled strategies to improve tuberculosis treatment adherence
Muniyandi, M., Salam, S. A., & Nagarajan, K. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2691181 · Cited by 1
Triana, R., Pujiyanto, P., & Chandra, E. (2023) · J-KESMAS Jurnal Kesehatan Masyarakat · doi:10.35329/jkesmas.v9i2.4823 · Cited by 3
Technology and its role in supporting Tuberculosis treatment adherencePreprint
Kale, E. D., & Pandin, M. G. R. (2021) · Research Square · doi:10.21203/rs.3.rs-1187802/v1 · Cited by 1
Musa, Z. A., Akinsolu, F. T., Salako, A. O., Abodunrin, O. R., Ola, O. M., & Ezechi, O. C. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1529289
Rethinking the benefits of digital adherence technologies for tuberculosis treatment
Marx, F. M., & Civan, A. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00199-0
Leveraging technology to improve tuberculosis patient adherence: a comprehensive review
Fahrana, A., Hernawati, S., Bukhori, S., Munawir, A., & Putra, B. A. M. (2025) · TELKOMNIKA (Telecommunication Computing Electronics and Control) · doi:10.12928/telkomnika.v23i3.26176
Ahmad, D., Kazmi, S. K., Ilyas, U., Hashmi, G. M., Shahid, M. A., Shah, S., & Babur, M. (2025) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v8i6.1247
Assessing Mediation in Cross‐Sectional Stepped Wedge Cluster Randomized Trials
Cao, Z., & Li, F. (2025) · Statistics in Medicine · doi:10.1002/sim.70175 · Cited by 2
Wambi, P., West, S. N., Nabugoomu, J., Kityamuwesi, A., Crowder, R., Tinka, L. K., Wobudeya, E., Cattamanchi, A., Jaganath, D., & Katamba, A. (2025) · SSM - Health Systems · doi:10.1016/j.ssmhs.2025.100151
Self-citationDina, T. J., Imon, T. A. K., Das, P., Mitu, M., Mahjabeen, S., Kaderi, N. B., Nafis, R., Chowdhury, A. J., & Fatema, N. (2025) · Journal of medical & health sciences review. · doi:10.65035/95t9js48
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · Figshare · doi:10.6084/m9.figshare.21220184
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · Figshare · doi:10.6084/m9.figshare.21220172
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · Figshare · doi:10.6084/m9.figshare.21220175
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · Figshare · doi:10.6084/m9.figshare.21220178
Foster, N., Tadesse, A. W., McQuaid, C. F., Goscé, L., Abdurhman, T., Assefa, D., Bedru, A., Houben, R. M. G. J., van Kalmthout, K., Letta, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26584425
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · Figshare · doi:10.6084/m9.figshare.21220181
Digital Adherence Support for Tuberculosis Treatment: A Multicentre Randomized Trial in KenyaPreprint
Yoeli, E., Rathauser, J., Nyakan, E., Boutilier, J. J., Campbell, J. R., Chilo, M., Irungu, L. M., Jónasson, J. O., Kimenye, M. K., Muchiri, F. K., et al. (2026) · medRxiv · doi:10.64898/2026.02.11.26346015
Ahmad, R., Ramos, J. P., Duarte, R. S., Lange, C. G., & van Rest, J. (2026) · Breathe · doi:10.1183/20734735.0173-2025 · Cited by 2
Syah, F. Z. N., Susanto, N. A., & Zainuri, A. (2026) · PHARMADEMICA Jurnal Kefarmasian dan Gizi · doi:10.54445/pharmademica.v5i2.160
Benbrik, O., Bounar, O., Chakri, I., Lahlou, L., & Serhane, H. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13586-y
Wiafe, E., Ubani, C., Charles, R., Abaneme, D., Akinyemi, J. S., & Moshood, K. O. (2026) · Discover Public Health · doi:10.1186/s12982-026-02197-2
Lessons learned from people-centred TB care and support interventions in the Russian Federation
Stavitskaya, N. V., Felker, I., Nemkova, Е. К., Vujnovic, M., Berdyklychev, B., & Yegeubayeva, S. (2026) · IJTLD OPEN · doi:10.5588/ijtldopen.25.0844
Thompson, R. R., Ryuk, D. K., Pelissari, D. M., Harada, L. O., Júnior, J. N. D. B. S., Bartholomay, P., Johansen, F. D. C., Sánchez, M., Cohen, T., Castro, M. C., et al. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag434
Herawati, F., & Kartikasari, D. (2026) · Jurnal Ilmiah Ilmu Keperawatan Indonesia · doi:10.33221/jiiki.v16i02.4464
Treatment Adherence in Patients with Tuberculosis: An Integrative Review
Natalia, G. D., Irwan, A. M., & Buckenmeyer, A. C. (2025) · Journal of Education and Community Health · doi:10.34172/jech.3160
Papineni, S., Jandhyala, P., Sharma, K. K., Singh, A. K., Ghosh, S., Verma, D., Chaudhari, A., Bhaskar, R., Sachdeva, A., & Deo, S. (2026) · doi:10.12688/verixiv.3831.1
Halkiewicz, S. M., & Alexeev, S. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.23759101
DAT should be an Adjunct Not a Replacement for DOT
Ravichandra, C., & Sharath, B. N. (2026) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2026.11.001
Metadata
- Authors
- Cattamanchi, A., Crowder, R., Kityamuwesi, A., Kiwanuka, N., Lamunu, M., Namale, C., Tinka, L. K., Nakate, A. S., Ggita, J., Turimumahoro, P., Babirye, D., Oyuku, D., Berger, C., Tucker, A., Patel, D., Sammann, A., Turyahabwe, S., Dowdy, D., & Katamba, A.
- Affiliations
- San Francisco General Hospital (US)
- Makerere University (UG)
- Johns Hopkins University (US)
- Ministry of Health (UG)
- Corresponding author
- Cattamanchi, Adithya
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-05-06
- Volume
- 18
- Issue
- 5
- Pages
- e1003628
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC8136841
- OpenAlex
- W3157487954
- Cited by
- 83
- References
- 21
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 15 · 2023: 17 · 2022: 14 · 2021: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-05-20)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- The Stop TB Partnership (STBP/TBREACH/GSA/W6-37, (STBP/TBREACH/GSA/W6-37))
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- tuberculosis, digital adherence technologies, treatment supervision, treatment completion, drug-susceptible pulmonary tuberculosis, HIV coinfection, sex differences, Uganda, mobile health
- MeSH terms
- Assessment of Medication Adherence, Adult, Antitubercular Agents, Female, Humans, Male, Middle Aged, Technology, Tuberculosis, Pulmonary, Uganda, Cluster Analysis, Drug Monitoring, Medication Adherence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.